Brief: Seastar Medical Issued U.S. Patent With Broad Claims Covering Use Of The Selective Cytopheretic Device
09/01/2024 14:22
Jan 9 (Reuters) - SeaStar Medical Holding Corp ICU.O :
* SEASTAR MEDICAL ISSUED U.S. PATENT WITH BROAD CLAIMS
COVERING
USE OF THE SELECTIVE CYTOPHERETIC DEVICE FOR MULTIPLE CLINICAL
INDICATIONS
Source text for Eikon: ID:nGNX3MK1Hg
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview